Publications by authors named "Eleanor C Hobaugh"
Article Synopsis
- The study explored the feasibility of enrolling cancer patients to assess chemotherapy-induced peripheral neuropathy (CIPN) and test a potential preventive intervention.
- 28 out of 33 approached patients consented to participate, completing a neurotoxicity questionnaire at three time points during treatment.
- Results showed a significant decline in neurotoxicity scores over time, with 67% of patients experiencing clinically meaningful CIPN within 12 weeks of chemotherapy.
Introduction: The safety and efficacy of direct oral anticoagulants in cancer patients is currently unclear. Low-molecular-weight heparin remains the standard of care for cancer patients with venous thromboembolism, with warfarin, a vitamin K antagonist, as an alternative. Clear recommendations do not exist for patients with both active cancer and non-valvular atrial fibrillation.
View Article and Find Full Text PDF